Dr. Nicholas Mai

Dr. Nicholas Mai, MD, is a medical oncologist and early drug development specialist at Memorial Sloan Kettering Cancer Center, where he sees patients at the MSK Monmouth location in New Jersey. His clinical focus is the treatment of breast cancer, with particular expertise in cancer genomics and genetic testing to guide individualized treatment planning. Dr. Mai approaches each patient's diagnosis as unique, taking care to ensure that patients feel informed and confident throughout their care. His practice is grounded in the principle, drawn from his mentors, that excellence in medicine is measured not by following a set path but by expertly navigating the complexity of each individual case.

Dr. Mai serves as one of the main clinical organizers of MSK's Molecular Tumor Board, a multidisciplinary forum that brings together medical oncologists, surgical oncologists, radiation oncologists, pathologists, and radiologists to discuss complex cases twice monthly. This collaborative group applies the latest data to help patients and providers identify the most appropriate treatment options or clinical trials. He also leads clinical trials through MSK's early drug development service, conducting groundbreaking studies that give patients access to promising new therapies before they are widely available, creating potential treatment paths when standard options have reached their limits.

Known for combining deep clinical knowledge with a calm and compassionate approach, Dr. Mai is committed to delivering expert, personalized care to every patient he treats. He uses tools including genetic testing and genomic analysis to match patients with treatments best suited to their specific cancer type and circumstances. Whether a case follows an expected course or presents uncommon challenges, he brings the full support of the MSK team to guide patients through their journey with clarity and confidence.